The procalcitonin (PCT) assay market is on a trajectory of notable growth, with projections indicating a rise from USD 280.6 million in 2023 to over USD 512.9 million by 2033. This represents a compound annual growth rate (CAGR) of 6.2% throughout the forecast period.
The PCT assay market, which encompasses diagnostic tests measuring the levels of procalcitonin—a precursor protein produced in response to bacterial infections—has experienced significant growth in recent years. This growth is largely attributed to the increasing awareness of the critical role early and accurate diagnosis plays in managing bacterial infections, as well as rising incidences of lung cancer, which further drive the demand for advanced diagnostic solutions.
Procalcitonin assays are instrumental in distinguishing bacterial infections from other types of infections and inflammatory conditions, making them a valuable tool in clinical settings. The growing recognition of procalcitonin’s diagnostic value, combined with advancements in assay technologies, is contributing to the market’s expansion.
Key Takeaways:
- Market Growth: The market is expected to experience substantial growth, with a projected valuation of $512.9 million by 2033, driven by a CAGR of 6.2% during the forecast period.
- Lung Cancer Incidences: The increasing incidence of lung cancer is a significant driver for market growth, underlining the need for early and accurate diagnosis of bacterial infections.
- Awareness and Importance: Growing awareness about the importance of early and precise diagnosis of bacterial infections has contributed to the market’s expansion.
- PCT Assay Definition: The market revolves around diagnostic tests that measure procalcitonin levels in the bloodstream. Procalcitonin is a precursor protein produced in response to bacterial infections.
- Enhanced Diagnostic Solutions: The PCT assay market is committed to offering advanced diagnostic solutions for bacterial infections, with the goal of improving patient care.
- Early Detection: PCT assays play a pivotal role in the early detection of bacterial infections, allowing for prompt treatment and better healthcare outcomes.
- Clinical Utility: Procalcitonin assays are valuable tools for clinicians to assess the presence and severity of bacterial infections, guiding treatment decisions.
- Patient Care: The focus on precise diagnosis and early intervention is aligned with providing optimal patient care and improving healthcare outcomes.
- Innovative Diagnostics: The market’s growth reflects ongoing innovations in diagnostic technologies and their impact on the field of bacterial infection detection.
- Global Impact: The Procalcitonin (PCT) Assay Market contributes to the global efforts to enhance healthcare by improving the accuracy and timeliness of bacterial infection diagnosis.
Key Players in the Procalcitonin (PCT) Assay Market:
- J. Mitra & Co. Pvt. Ltd.
- Thermo Fisher Scientific Inc.
- Elabscience Biotechnology Inc.
- CUSABIO TECHNOLOGY LLC
- Wuhan Fine Biotech Co., Ltd.
- Company ABclonal, Inc.
- Nanjing Vazyme Biotech Co.,Ltd.
- RayBiotech Life, Inc.
- Hipro Biotechnology Co.,Ltd.
- Vitrosens Biotechnology
- bioMérieux SA
- ELK Biotechnology CO.,Ltd.
- Immuno-Biological Laboratories, Inc.
- BISAF
- Roche Diagnostics
Key Developments:
- In November 2020, Roche and bioMérieux announced a collaboration to improve antibiotic stewardship by developing and providing PCT assays on Roche’s cobas platforms.
- In February 2020, bioMérieux received FDA clearance for the Vidas BRAHMS PCT assay, which is an automated immunoassay platform for measuring PCT levels.
A Old Full Report Analysis Click Here
Procalcitonin (PCT) Assay Market Segmentation:
By Sample Type:
- Serum
- Plasma
- Cell Culture Medium
- Other Biological Fluids
By Product:
- Test Kits
- Procalcitonin ELISA test kits
- Procalcitonin CLIA kits
- PCT Immunochromatography KITS
- PCT Rapid Test Kit
- Analyzer & Instruments
- Consumables
By Purpose:
- Clinical Use
- Research Use Only
By End User:
- Hospital
- Specialty Clinics
- Academic and Research Institute
- Diagnostics Laboratories
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube